Pharsight

ABBOTT LABORATORIES PATENTS FACING OPPOSITIONS

Top patents of ABBOTT LABORATORIES facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP2708147B1 11 Mar, 2020 Methods for increasing brain functionality using 2-fucosyl-lactose Sep, 2032 3
EP3410874B1 05 May, 2021 Whey protein based liquid nutritional composition NA 2
EP3338784B1 22 Jul, 2020 Human milk oligosaccharides for modulating inflammation Dec, 2031 2
EP2658549B1 03 Jun, 2020 Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents Dec, 2031 2
EP2658399B2 27 Feb, 2019 Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection NA 2
EP2934160B1 14 Nov, 2018 Low viscosity, high caloric density oral nutritional composition and related methods NA 2
EP2658548B1 21 Feb, 2018 Human milk oligosaccharides for modulating inflammation NA 2
EP2734210B1 22 Nov, 2017 Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract Jul, 2032 2
EP2802322B1 Combination of beta-hydroxy-beta-methylbutyrate, arginine and glutamine for use in treating diabetic ulcers NA 1
EP2903458B1 Methods for enhancing the effect of egcg on mitigating skeletal muscle loss NA 1
EP3599898B1 17 Aug, 2022 Liquid nutritional compositions containing oxidizable fish oil, rosmarinic acid and ferric iron Mar, 2038 1
EP3328214B1 01 Apr, 2020 Nutritional products having improved lipophilic solubility and bioavailability in an easily mixable form NA 1
EP3043658B1 20 Nov, 2019 Nutritional composition having lipophilic compounds with improved solubility and bioavailability NA 1
EP2934189B1 06 Nov, 2019 Human milk oligosaccharides to ameliorate symptoms of stress Dec, 2033 1
EP2658546B1 05 Dec, 2018 Methods of using human milk oligosaccharides for improving airway respiratory health Dec, 2031 1
EP2283736B1 30 May, 2018 Infant formulas containing docosahexaenoic acid and lutein NA 1
EP2278002B1 12 Jul, 2017 Pancreatin with reduced viral content Jul, 2026 1